| [1] |
Zhang XG,Yao LB.The signal transduction pathway and function of Eph receptors and its ligands[J].Prog Biochem Biophy(生物化学和生物物理学进展),2001,28(4):498-501.
|
| [2] |
Sun JF,Liu HJ,Li C.Relationship between expressions of EphB4 with angiogenesis in human colorectal carcinoma[J].J Frontier Med(医药前沿),2013,5(21):250-255.
|
| [3] |
Bardelle C,Cross D,Davenport S,et al.Inhibitors of the tyrosine kinase EphB4.Part 1:structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines[J].Bioorg Med Chem Lett,2008,18(2):2776-2780.
|
| [4] |
Bardelle C,Coleman T,Cross D,et al.Inhibitors of the tyrosine kinase EphB4.Part 2:structure-based discovery and optimisation of 3,5-bis substituted anilinopyrimidines[J].Bioorg Med Chem Lett,2008,18(5):5717-5721.
|
| [5] |
Barlaam B, Ducray R, Read J, et al. Inhibitors of the tyrosine kinase EphB4.Part 4:discovery and optimization of a benzylic alcohol series[J].Bioorg Med Chem Lett,2011,21(22):2207-2211.
|
| [6] |
Lafleur K,Huang D,Zhou T,et al.Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4(EphB4)[J].J Med Chem,2009,52(6):6433-6446.
|
| [7] |
Lafleur K,Dong J,Huang D,et al.Optimization of inhibitors of the tyrosine kinase EphB4.2.Cellular potency improvement and binding mode validation by X-ray crystallography[J].J Med Chem,2013,56(1):84-96.
|
| [8] |
Miyazaki Y,Nakano M,Sato M,et al.Design and effective synthesis of novel templates,3,7-diphenyl-4-amino-thieno and furo-[3,2-c]pyridines as protein kinase inhibitors and in vitro evaluation targeting angiogenetic kinases[J].Bioorg Med Chem Lett,2007,17(2):250-254.
|
| [9] |
Mitchell SA,Danca MD,Blomgren PA,et al.Imidazo[1,2-a]pyrazine diaryl ureas:inhibitors of the receptor tyrosine kinase EphB4[J].Bioorg Med Chem Lett,2009,19(6):6991-6995.
|
| [10] |
Fischer R.The Principle of Experimentation,Illustrated by a Psycho-Physical Experiment,in the Design of Experiments[M].New York:Hafner Publishing Company,1966:129-153.
|
| [11] |
Walters WP,Murcko MA.Prediction of ‘drug-likeness’[J].Adv Drug Delivery Rev,2002,54(2):255-271.
|
| [12] |
Cheng A, Merz KM Jr. Prediction of aqueous solubility of a diverse set of compounds using quantitative structure-property relationships[J].J Med Chem,2003,46(3):3572-3580.
|
| [13] |
Vermunt JE,Magidson J.Latent GOLD 5.0 Upgrade Manual[M].Belmont:Statistical Innovations Inc.,2013:540-555.
|
百度学术
下载:
